Select Medical Holdings Co. (NYSE:SEM) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Select Medical Holdings Co. (NYSE:SEM - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the five brokerages that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $26.80.

A number of research analysts recently issued reports on the company. Mizuho began coverage on Select Medical in a report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 target price on the stock. Benchmark raised Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target on the stock in a report on Monday, February 24th. Royal Bank of Canada cut their target price on Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a research report on Monday, February 24th. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. Finally, UBS Group reduced their price target on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a research report on Friday, January 3rd.

Select Medical Stock Performance

Select Medical stock traded down $1.17 during mid-day trading on Wednesday, hitting $15.19. 230,880 shares of the company's stock traded hands, compared to its average volume of 814,307. Select Medical has a one year low of $14.99 and a one year high of $40.98. The firm has a 50 day moving average price of $17.27 and a 200 day moving average price of $22.83. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The company has a market cap of $1.96 billion, a PE ratio of 9.21, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The company had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. On average, equities analysts forecast that Select Medical will post 1.17 EPS for the current year.

Select Medical Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd were given a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.65%. The ex-dividend date was Monday, March 3rd. Select Medical's payout ratio is currently 15.15%.

Hedge Funds Weigh In On Select Medical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Smartleaf Asset Management LLC boosted its holdings in Select Medical by 179.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after purchasing an additional 1,473 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Select Medical in the 3rd quarter valued at approximately $81,000. Covestor Ltd boosted its position in Select Medical by 33.5% during the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after purchasing an additional 1,244 shares during the period. GAMMA Investing LLC grew its holdings in Select Medical by 217.4% during the first quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock valued at $109,000 after purchasing an additional 4,453 shares during the last quarter. Finally, Lazard Asset Management LLC raised its position in shares of Select Medical by 47.8% in the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock valued at $130,000 after purchasing an additional 2,255 shares during the period. Institutional investors own 89.48% of the company's stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.